Neuralink

Neuralink is an American neurotechnology company founded in 2016 by Elon Musk and a team of scientists and engineers. The company focuses on developing implantable brain-computer interfaces (BCIs) to treat neurological disorders and enhance human cognition. Neuralink's core product is the N1 Implant, also known as "the Link," which features flexible polymer threads that record and stimulate brain activity, allowing for real-time communication with external devices. The company has made significant advancements in BCI technology, including receiving FDA approval for human trials in May 2023. In January 2024, Neuralink implanted its first device in a paralyzed patient, enabling them to control devices, play chess, and learn languages through thought. Neuralink's mission includes creating a generalized brain interface for treating serious brain conditions and exploring long-term human enhancement possibilities.